Hematologists face the challenge of incorporating Target Therapies into daily practice in the treatment of acute leukemia Published on 10/11/2021 Better understanding of cell tumor biology opens possibilities for targeted therapies in acute leukemia
Systemic mastocytosis, a disease of rare diagnosis, to be studied at the 10th Acute Leukemia Conference of MD Anderson Madrid Published on 27/09/2021 It will feature prominent speakers from different countries in America and Europe, as well as the intervention of professionals from the MD Anderson leukemia department in Houston
IDH inhibitors give very positive results in relapsed acute myeloblastic leukemia patients with the mutation Published on 08/10/2019 Acting on this therapy target would give favorable results in both monotherapy and in combination with other agents, thus improving life expectancy of patients with acute myeloblastic leukemia (AML)